Literature DB >> 15364432

Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.

Suh-Chin Wu1, Chia-Chyi Liu, Wei-Cheng Lian.   

Abstract

Enterovirus 71 (EV71) is an enterovirus that could lead to severe neurological disorders and fatalities. The inactivated vaccine is an appropriate EV71 vaccine format for meeting current needs. Large-scale preparation of the inactivated EV71vaccine depends on a scalable cell culture system for industrial mass production. In this paper, Vero cells were found to produce higher titers of EV71 than did MRC-5 and WI-38 cells. High-density microcarrier Vero cell cultures were established using 5g/L Cytodex 1 microcarriers and found to promote the release of EV71s from infected Vero cells. For the large-scale production of the inactivated vaccine antigen, the extracellular virus titers produced in the 2L bioreactor were found to be 10 times lower than the spinner flask culture but improved by 30-folds using glucose/glutamine feedings during infection. A serum-free Vero cell microcarrier culture was also established in the bioreactor, yielding a high-titer of 5.8 x 10(7) TCID50/mL for EV71 production. The immunogenicity of the inactivated virions produced in serum-free culture elicited a slightly higher level of neutralizing antibody response in immunized mice. These results constitute valuable information on the development of a large-scale microcarrier cell culture process for producing inactivated EV71 vaccine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364432     DOI: 10.1016/j.vaccine.2004.05.037

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Process optimization for the rapid production of Enterovirus 71.

Authors:  Xiao-Xin Wu; Ke-Da Chen; Da-Zhi Chen; Lan-Lan Xiao; Kai-Zhou Huang; Yan-Jun Zhang; Lan-Juan Li
Journal:  Cytotechnology       Date:  2019-09-26       Impact factor: 2.058

2.  Carbohydrates-chitosan composite carrier for Vero cell culture.

Authors:  Ya-Ching Lin; Guan-Ting Chen; Sheng-Chi Wu
Journal:  Cytotechnology       Date:  2016-10-05       Impact factor: 2.058

3.  Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.

Authors:  Minqing Gong; Hongtao Zhu; Jun Zhou; Chunting Yang; Jing Feng; Xiaojun Huang; Gang Ji; Honglin Xu; Ping Zhu
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

Review 4.  Progress on the research and development of human enterovirus 71 (EV71) vaccines.

Authors:  Zhenglun Liang; Qunying Mao; Fan Gao; Junzhi Wang
Journal:  Front Med       Date:  2012-12-17       Impact factor: 4.592

5.  A serum-free Vero production platform for a chimeric virus vaccine candidate.

Authors:  Inn H Yuk; Gina B Lin; Hui Ju; Inesse Sifi; Yvonne Lam; Armida Cortez; Danny Liebertz; J Michael Berry; Richard M Schwartz
Journal:  Cytotechnology       Date:  2006-11-16       Impact factor: 2.058

Review 6.  Production of EV71 vaccine candidates.

Authors:  Pele Chong; Shih-Yang Hsieh; Chia-Chyi Liu; Ai-Hsiang Chou; Jui-Yuan Chang; Suh-Chin Wu; Shih-Jen Liu; Yen-Hung Chow; Ih-Jen Su; Michel Klein
Journal:  Hum Vaccin Immunother       Date:  2012-09-19       Impact factor: 3.452

7.  Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.

Authors:  Chia-Chyi Liu; Meng-Shin Guo; Fion Hsiao-Yu Lin; Kuang-Nan Hsiao; Kate Hsuen-Wen Chang; Ai-Hsiang Chou; Yu-Chao Wang; Yu-Ching Chen; Chung-Shi Yang; Pele Choi-Sing Chong
Journal:  PLoS One       Date:  2011-05-13       Impact factor: 3.240

8.  Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium.

Authors:  Alan Yung-Chih Hu; Yu-Fen Tseng; Tsai-Chuan Weng; Chien-Chun Liao; Johnson Wu; Ai-Hsiang Chou; Hsin-Ju Chao; Anna Gu; Janice Chen; Su-Chen Lin; Chia-Hsin Hsiao; Suh-Chin Wu; Pele Chong
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

9.  Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71.

Authors:  Yi-Wen Lin; Shu-Ling Yu; Hsiao-Yun Shao; Hsiang-Yin Lin; Chia-Chyi Liu; Kuang-Nan Hsiao; Ebenezer Chitra; Yueh-Liang Tsou; Hsuen-Wen Chang; Charles Sia; Pele Chong; Yen-Hung Chow
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Immunological and biochemical characterization of coxsackie virus A16 viral particles.

Authors:  Pele Chong; Meng-Shin Guo; Fion Hsiao-Yu Lin; Kuang-Nan Hsiao; Shu-Yang Weng; Ai-Hsiang Chou; Jen-Ren Wang; Shih-Yang Hsieh; Ih-Jen Su; Chia-Chyi Liu
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.